Comparison of 2 effect-site concentrations of remifentanil with midazolam during transrectal ultrasound-guided prostate biopsy under procedural analgesia and sedation: A randomized controlled study

Hou-Chuan Lai, Chin-Li Chen, Yi-Hsuan Huang, Ke-Li Wu, Ren-Chih Huang, Bo-Feng Lin, Shun-Ming Chan, Zhi-Fu Wu, Hou-Chuan Lai, Chin-Li Chen, Yi-Hsuan Huang, Ke-Li Wu, Ren-Chih Huang, Bo-Feng Lin, Shun-Ming Chan, Zhi-Fu Wu

Abstract

Background: Until now, target-controlled infusion of remifentanil with midazolam for transrectal ultrasound-guided prostate biopsy has not been described. Here, we investigate 2 effect-site concentrations of remifentanil with intermittent bolus midazolam for transrectal ultrasound-guided prostate biopsy under procedural analgesia and sedation.

Methods: A prospective, randomized controlled trial including patients who received a transrectal ultrasound-guided prostate biopsy between February 2019 and January 2021 was conducted. Group 1 and Group 2 were respectively administered an initial effect-site concentration of remifentanil of 1.0 ng/mL and 2.0 ng/mL by a target-controlled infusion pump with Minto model. In both groups, maintenance of the effect-site concentration of remifentanil was adjusted upward and downward by 0.5 ng/mL to keep patient comfort with acceptable pain (remaining moveless), and mean arterial pressure and heart rate within baseline levels ± 30%, and using intermittent bolus midazolam to keep the Observer's Assessment of Alertness/Sedation scale between 2 and 4. The primary outcome was to determine which effect-site concentration of remifentanil provide adequate patient comfort with acceptable pain (remaining moveless) during the procedure.

Results: A total of 40 patients in Group 1 and 40 patients in Group 2 were eligible for analysis. Most parameters were insignificantly different between Group 1 and Group 2, except Group 1 having higher peripheral oxygen saturation while probe insertion compared with Group 2. Group 2 patients had less intraoperative movements affecting the procedure (2 vs 18; P < .001), and less total times of target-controlled infusion pump adjustment (0 [0-1] vs 1 [0-3], P < .001) compared with group 1. However, group 1 patients had less apnea with desaturation (peripheral oxygen saturation < 90%; 0 vs 9, P = .002) and less remifentanil consumption (94.9 ± 25.5 μg vs 106.2 ± 21.2 μg, P = .034) compared to Group 2.

Conclusion: In transrectal ultrasound-guided prostate biopsy, target-controlled infusion with remifentanil Minto model target 2.0 ng/mL with 3 to 4 mg midazolam use provided sufficient analgesia and sedation, and appropriate hemodynamic and respiratory conditions.

Conflict of interest statement

The authors have no funding and conflicts of interest to disclose.

Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.

References

    1. Kang SG, Tae BS, Min SH, et al. Efficacy and cost analysis of transrectal ultrasound-guided prostate biopsy under monitored anesthesia. Asian J Androl. 2011;13:724–7.
    1. Doğanca T, Savsin A, Erdoğan S, et al. Procedural sedation and analgesia as an adjunct to periprostatic nerve block for prostate biopsy: a prospective randomized trial. J Clin Ultrasound. 2015;43:288–94.
    1. Lee C, Woo HH. Current methods of analgesia for transrectal ultrasonography (TRUS)-guided prostate biopsy -- a systematic review. BJU Int. 2014;113(Suppl 2):48–56.
    1. Arora S. Combining ketamine and propofol (“ketofol”) for emergency department procedural sedation and analgesia: a review. West J Emerg Med. 2008;9:20–3.
    1. Lai HC, Wu TS, Lai MF, et al. A comparison of two proportions of remifentanil–propofol mixture administered with target‐controlled infusion for patients undergoing colonoscopy. J Med Sci. 2020;40:272–8.
    1. Vuyk J. Pharmacokinetic and pharmacodynamic interactions between opioids and propofol. J Clin Anesth. 1997;9:23s–6s.
    1. Santonocito C, Noto A, Crimi C, et al. Remifentanil-induced postoperative hyperalgesia: current perspectives on mechanisms and therapeutic strategies. Local Reg Anesth. 2018;11:15–23.
    1. Sagiroglu G, Baysal A. Continuous intravenous versus intermittent bolus midazolam with remifentanil during arteriovenous fistula placement with monitored anesthesia care in chronic renal failure patients: a randomized controlled trial. Ann Saudi Med. 2020;40:175–82.
    1. Z Al-Rifai DM. Principles of total intravenous anaesthesia: basic pharmacokinetics and model descriptions. BJA Education. 2016;16:92–7.
    1. Lai HC, Tsai YT, Huang YH, et al. Comparison of 2 effect-site concentrations of remifentanil with midazolam during percutaneous transluminal balloon angioplasty under monitored anesthesia care: a randomized controlled study. Medicine (Baltim). 2021;100:e26780.
    1. Avramov MN, Smith I, White PF. Interactions between midazolam and remifentanil during monitored anesthesia care. Anesthesiology. 1996;85:1283–9.
    1. Davis P, Paul E, Grummet J. Current practice of prostate biopsy in Australia and New Zealand: a survey. Urol Ann. 2015;7:315–9.
    1. Lee C, Woo HH. Current methods of analgesia for transrectal ultrasonography (TRUS)-guided prostate biopsy -- a systematic review. BJU Int. 2014;113(Suppl 2):48–56.
    1. Park JY, Park SJ, Choi SU, et al. Target-controlled propofol infusion for sedation in patients undergoing transrectal ultrasound-guided prostate biopsy. J Int Med Res. 2007;35:773–80.
    1. Sohn HM, Ryu JH. Monitored anesthesia care in and outside the operating room. Korean J Anesthesiol. 2016;69:319–26.
    1. Song JW, Soh S, Shim JK. Monitored Anesthesia Care for Cardiovascular Interventions. Korean Circ J. 2020;50:1–11.
    1. Yao T, Wang DX, Feng QS, et al. The application of remifentanil-propofol and remifentanil-midazolam analgesia for choledochofiberscopic dilatation of bile duct. Zhonghua Yi Xue Za Zhi. 2011;91:626–9.
    1. Ozveri H, Cevik I, Dillioglugil O, et al. Transrectal periprostatic lidocaine injection anesthesia for transrectal prostate biopsy: a prospective study. Prostate Cancer Prostatic Dis. 2003;6:311–4.
    1. Klein T, Palisaar RJ, Holz A, et al. The impact of prostate biopsy and periprostatic nerve block on erectile and voiding function: a prospective study. J Urol. 2010;184:1447–52.
    1. Izol V, Soyupak B, Seydaoglu G, et al. Three different techniques for administering analgesia during transrectal ultrasound-guided prostate biopsy: a comparative study. Int Braz J Urol. 2012;38:122–8.
    1. Naidoo A, Heyns CF, Aziz NA, et al. A prospective randomized study of periprostatic lignocaine injection versus intrarectal lignocaine gel or placebo gel for pain relief during transrectal ultrasound guided needle biopsy of the prostate. Afr J Urol. 2006;12:65–74.
    1. Aslan R, Erbin A, Eryilmaz R, et al. Comparative evaluation of bilateral pudendal nerve blockade and periprostatic nerve block in transrectal ultrasound guided prostate biopsy: a prospective randomised trial. Cent European J Urol. 2020;73:140–5.
    1. Peng CW, Chen JJ, Cheng CL, et al. Role of pudendal afferents in voiding efficiency in the rat. Am J Physiol Regul Integr Comp Physiol. 2008;294:R660–72.
    1. Litman RS. Conscious sedation with remifentanil and midazolam during brief painful procedures in children. Arch Pediatr Adolesc Med. 1999;153:1085–8.
    1. Bailey PL, Pace NL, Ashburn MA, et al. Frequent hypoxemia and apnea after sedation with midazolam and fentanyl. Anesthesiology. 1990;73:826–30.
    1. Myles PS, Leslie K, McNeil J, et al. Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomised controlled trial. Lancet. 2004;363:1757–63.
    1. Gao WW, He YH, Liu L, et al. BIS monitoring on intraoperative awareness: a meta-analysis. Curr Med Sci. 2018;38:349–53.
    1. Jun MR, Yoo JH, Park SY, et al. Assessment of phase-lag entropy, a new measure of electroencephalographic signals, for propofol-induced sedation. Korean J Anesthesiol. 2019;72:351–6.
    1. Funcke S, Sauerlaender S, Pinnschmidt HO, et al. Validation of innovative techniques for monitoring nociception during general anesthesia: a clinical study using tetanic and intracutaneous electrical stimulation. Anesthesiology. 2017;127:272–83.
    1. Inal G, Adsan O, Ugurlu O, et al. Comparison of four different anesthesia methods for relief of all pain during transrectal ultrasound-guided prostate biopsy. Int Urol Nephrol. 2008;40:335–9.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir